| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 1.13e-05 | 12 | 252 | 4 | GO:0016175 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ACAP1 ELMOD2 MYO9B HMGCR PLEKHG5 TBC1D24 SLIT2 SRGAP1 ARHGAP44 VAV3 DENND5A HERC1 DOCK6 IQGAP3 STXBP5L GPS1 DGKI ARHGAP28 PLCE1 | 2.58e-05 | 507 | 252 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ACAP1 ELMOD2 MYO9B HMGCR PLEKHG5 TBC1D24 SLIT2 SRGAP1 ARHGAP44 VAV3 DENND5A HERC1 DOCK6 IQGAP3 STXBP5L GPS1 DGKI ARHGAP28 PLCE1 | 2.58e-05 | 507 | 252 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 1.02e-04 | 20 | 252 | 4 | GO:0050664 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.28e-04 | 118 | 252 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 1.59e-04 | 2 | 252 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | interleukin-8 receptor activity | 1.59e-04 | 2 | 252 | 2 | GO:0004918 | |
| GeneOntologyMolecularFunction | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 4.72e-04 | 3 | 252 | 2 | GO:0047237 | |
| GeneOntologyMolecularFunction | interleukin-8 binding | 4.72e-04 | 3 | 252 | 2 | GO:0019959 | |
| GeneOntologyMolecularFunction | GTPase inhibitor activity | 5.17e-04 | 13 | 252 | 3 | GO:0005095 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | ADCY10 KIF1A SPEF2 ASH1L DRC1 FSIP2 UBB DST STARD9 SYNE2 C2CD6 DNAH8 KLC3 KLC1 KIF13B HDAC6 KLC2 AP3B1 WDR19 TRAK2 CFAP46 | 6.92e-07 | 493 | 250 | 21 | GO:0007018 |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 5.59e-06 | 22 | 250 | 5 | GO:0050665 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | ADCY10 KIF1A SPEF2 UBB DST SYNE2 KLC3 KLC1 HDAC6 KLC2 AP3B1 WDR19 TRAK2 | 1.39e-05 | 253 | 250 | 13 | GO:0099111 |
| GeneOntologyBiologicalProcess | Fc receptor mediated inhibitory signaling pathway | 1.73e-05 | 5 | 250 | 3 | GO:0002774 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | KIF1A UBB DST SYNE2 KLC3 KLC1 KIF13B HDAC6 KLC2 AP3B1 WDR19 TRAK2 | 2.07e-05 | 225 | 250 | 12 | GO:0030705 |
| GeneOntologyBiologicalProcess | neuromuscular process | MYH3 ZMPSTE24 MYO7A ADCY5 ABCC8 CCDC78 HERC1 ROGDI GRIN2A GSTM2 PDE8B TNNT1 | 2.07e-05 | 225 | 250 | 12 | GO:0050905 |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 VPS11 SPAG1 MYO7A SPEF2 ENTR1 DRC1 TUBGCP5 TBC1D24 ABRAXAS2 FSIP2 STARD9 SYNE2 CCDC78 ASPM BOP1 PLEC DNAH8 WNK3 KLC3 NRAP HDAC6 SYNE1 INO80 AP3B1 WDR19 CEP89 ATM FSCN1 TNNT1 CFAP46 | 2.14e-05 | 1138 | 250 | 31 | GO:0070925 |
| GeneOntologyBiologicalProcess | axo-dendritic transport | 2.56e-05 | 98 | 250 | 8 | GO:0008088 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 3.00e-05 | 197 | 250 | 11 | GO:0010970 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 3.43e-05 | 6 | 250 | 3 | GO:0031554 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 6.06e-05 | 35 | 250 | 5 | GO:0045932 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | SPAG1 SPEF2 ENTR1 DRC1 TBC1D24 FSIP2 SLIT2 CYFIP1 SYNE2 ARHGAP44 VAV3 PLD1 DNAH8 KLC3 HDAC6 SYNE1 WDR19 CEP89 FSCN1 CFAP46 PLCE1 | 7.26e-05 | 670 | 250 | 21 | GO:0120031 |
| GeneOntologyBiologicalProcess | microtubule-based process | ADCY10 SPAG1 KIF1A SPEF2 ASH1L DRC1 TUBGCP5 LYST ABRAXAS2 FSIP2 UBB DST STARD9 SYNE2 CCDC78 ASPM C2CD6 DNAH8 KLC3 KLC1 KIF13B HDAC6 KLC2 INO80 AP3B1 WDR19 TRAK2 CFAP46 | 9.05e-05 | 1058 | 250 | 28 | GO:0007017 |
| GeneOntologyBiologicalProcess | cell projection assembly | SPAG1 SPEF2 ENTR1 DRC1 TBC1D24 FSIP2 SLIT2 CYFIP1 SYNE2 ARHGAP44 VAV3 PLD1 DNAH8 KLC3 HDAC6 SYNE1 WDR19 CEP89 FSCN1 CFAP46 PLCE1 | 9.90e-05 | 685 | 250 | 21 | GO:0030031 |
| GeneOntologyBiologicalProcess | interleukin-8-mediated signaling pathway | 1.46e-04 | 2 | 250 | 2 | GO:0038112 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1.46e-04 | 2 | 250 | 2 | GO:0050653 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide metabolic process | 1.61e-04 | 67 | 250 | 6 | GO:0042743 | |
| GeneOntologyBiologicalProcess | immune response-inhibiting cell surface receptor signaling pathway | 1.98e-04 | 10 | 250 | 3 | GO:0002767 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 2.18e-04 | 25 | 250 | 4 | GO:0046058 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | VPS11 ACAP1 ZMPSTE24 KIF1A LILRB2 TLR8 TBC1D24 UBB UBC PTPRC ABCC8 SNX8 GPR89A PLD1 EPN3 GPR89B ANPEP PLEKHF1 ANXA6 ATP13A5 GRIN2A ATP9A AP3B1 SLC12A2 LRP2 CD274 TMEM30A DGKI UNC13C ATM LYN CXCR1 CXCR2 | 4.66e-05 | 1307 | 252 | 33 | GO:0030659 |
| GeneOntologyCellularComponent | NADPH oxidase complex | 5.52e-05 | 18 | 252 | 4 | GO:0043020 | |
| GeneOntologyCellularComponent | vesicle membrane | VPS11 ACAP1 ZMPSTE24 KIF1A LILRB2 TLR8 TBC1D24 UBB UBC PTPRC ABCC8 SNX8 GPR89A PLD1 EPN3 GPR89B ANPEP PLEKHF1 ANXA6 ATP13A5 GRIN2A ATP9A AP3B1 SLC12A2 LRP2 CD274 TMEM30A DGKI UNC13C ATM LYN CXCR1 CXCR2 | 6.07e-05 | 1325 | 252 | 33 | GO:0012506 |
| GeneOntologyCellularComponent | axon | ADCY10 SETX KIF1A PLEKHG5 CNTN6 TBC1D24 SLIT2 CYFIP1 DST SYNJ2 SCN9A PLEC KLC1 KIF13B ROGDI HDAC6 GRIN2A AP3B1 LRP2 DGKI UNC13C TANC1 TRAK2 FSCN1 | 2.10e-04 | 891 | 252 | 24 | GO:0030424 |
| GeneOntologyCellularComponent | kinesin complex | 3.03e-04 | 49 | 252 | 5 | GO:0005871 | |
| Domain | - | ADCY10 VPS11 SPAG1 PSMD11 GTF3C3 KLC3 KLC1 ST7 GPS1 KLC2 WDR19 TTC17 TANC1 EDRF1 CFAP46 | 1.13e-07 | 207 | 247 | 15 | 1.25.40.10 |
| Domain | TPR-like_helical_dom | ADCY10 VPS11 SPAG1 PSMD11 GTF3C3 KLC3 KLC1 ST7 GPS1 KLC2 WDR19 TTC17 TANC1 EDRF1 CFAP46 | 5.24e-07 | 233 | 247 | 15 | IPR011990 |
| Domain | CH | 5.35e-06 | 73 | 247 | 8 | PS50021 | |
| Domain | CH-domain | 6.57e-06 | 75 | 247 | 8 | IPR001715 | |
| Domain | Kinesin_light | 9.05e-06 | 4 | 247 | 3 | IPR002151 | |
| Domain | CH | 2.35e-05 | 65 | 247 | 7 | SM00033 | |
| Domain | CH | 3.83e-05 | 70 | 247 | 7 | PF00307 | |
| Domain | IQ | 4.21e-05 | 71 | 247 | 7 | PF00612 | |
| Domain | - | 4.21e-05 | 71 | 247 | 7 | 1.10.418.10 | |
| Domain | Rab5-bind | 4.44e-05 | 6 | 247 | 3 | PF09311 | |
| Domain | Rabaptin_Rab5-bd_dom | 4.44e-05 | 6 | 247 | 3 | IPR015390 | |
| Domain | TPR | 7.10e-05 | 165 | 247 | 10 | PS50005 | |
| Domain | TPR_REGION | 7.10e-05 | 165 | 247 | 10 | PS50293 | |
| Domain | IQ | 9.83e-05 | 81 | 247 | 7 | SM00015 | |
| Domain | Gonadal | 1.74e-04 | 2 | 247 | 2 | IPR010849 | |
| Domain | Chemokine_CXCR_1/2 | 1.74e-04 | 2 | 247 | 2 | IPR000174 | |
| Domain | DGCR6 | 1.74e-04 | 2 | 247 | 2 | PF07324 | |
| Domain | DUOX1 | 1.74e-04 | 2 | 247 | 2 | IPR029595 | |
| Domain | TPR-contain_dom | 1.76e-04 | 150 | 247 | 9 | IPR013026 | |
| Domain | IQ_motif_EF-hand-BS | 1.91e-04 | 90 | 247 | 7 | IPR000048 | |
| Domain | ACTININ_2 | 2.17e-04 | 23 | 247 | 4 | PS00020 | |
| Domain | ACTININ_1 | 2.17e-04 | 23 | 247 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.17e-04 | 23 | 247 | 4 | IPR001589 | |
| Domain | IQ | 2.34e-04 | 93 | 247 | 7 | PS50096 | |
| Domain | Haem_peroxidase | 2.56e-04 | 10 | 247 | 3 | IPR010255 | |
| Domain | - | 2.56e-04 | 10 | 247 | 3 | 1.10.640.10 | |
| Domain | An_peroxidase | 2.56e-04 | 10 | 247 | 3 | PF03098 | |
| Domain | Haem_peroxidase_animal | 2.56e-04 | 10 | 247 | 3 | IPR019791 | |
| Domain | PEROXIDASE_3 | 2.56e-04 | 10 | 247 | 3 | PS50292 | |
| Domain | GST_C | 3.55e-04 | 26 | 247 | 4 | IPR004046 | |
| Domain | GST_C | 3.55e-04 | 26 | 247 | 4 | PF00043 | |
| Domain | FHA | 4.76e-04 | 28 | 247 | 4 | SM00240 | |
| Domain | KINESIN_LIGHT | 5.18e-04 | 3 | 247 | 2 | PS01160 | |
| Domain | Kinesin_light_repeat | 5.18e-04 | 3 | 247 | 2 | IPR015792 | |
| Domain | Spectrin_repeat | 5.47e-04 | 29 | 247 | 4 | IPR002017 | |
| Domain | ARM-type_fold | PDS5B VPS11 LYST NCAPG PIK3C2G ASPM GCN1 TARBP1 ARMC8 RICTOR AP3B1 ELMO3 ATM | 6.10e-04 | 339 | 247 | 13 | IPR016024 |
| Domain | FHA | 7.09e-04 | 31 | 247 | 4 | PF00498 | |
| Domain | Ubiquitin-rel_dom | 7.87e-04 | 184 | 247 | 9 | IPR029071 | |
| Domain | SPEC | 8.02e-04 | 32 | 247 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 8.02e-04 | 32 | 247 | 4 | IPR018159 | |
| Domain | C1_1 | 9.29e-04 | 57 | 247 | 5 | PF00130 | |
| Domain | ARM-like | PDS5B SETX NCAPG ASPM GCN1 TARBP1 HOMEZ ARMC8 RICTOR AP3B1 ELMO3 | 9.76e-04 | 270 | 247 | 11 | IPR011989 |
| Domain | GST_CTER | 1.01e-03 | 34 | 247 | 4 | PS50405 | |
| Domain | KASH | 1.03e-03 | 4 | 247 | 2 | PS51049 | |
| Domain | KASH | 1.03e-03 | 4 | 247 | 2 | PF10541 | |
| Domain | PBC | 1.03e-03 | 4 | 247 | 2 | PF03792 | |
| Domain | Kinesin-like_KIF1-typ | 1.03e-03 | 4 | 247 | 2 | IPR022140 | |
| Domain | KASH | 1.03e-03 | 4 | 247 | 2 | IPR012315 | |
| Domain | KIF1B | 1.03e-03 | 4 | 247 | 2 | PF12423 | |
| Domain | KASH | 1.03e-03 | 4 | 247 | 2 | SM01249 | |
| Domain | PBX | 1.03e-03 | 4 | 247 | 2 | IPR005542 | |
| Domain | TPR_1 | 1.24e-03 | 90 | 247 | 6 | IPR001440 | |
| Domain | TPR_1 | 1.24e-03 | 90 | 247 | 6 | PF00515 | |
| Domain | - | 1.26e-03 | 36 | 247 | 4 | 2.60.200.20 | |
| Domain | FHA_dom | 1.26e-03 | 36 | 247 | 4 | IPR000253 | |
| Domain | ZF_DAG_PE_2 | 1.57e-03 | 64 | 247 | 5 | PS50081 | |
| Domain | ZF_DAG_PE_1 | 1.57e-03 | 64 | 247 | 5 | PS00479 | |
| Domain | RUN | 1.61e-03 | 18 | 247 | 3 | SM00593 | |
| Domain | Nucleotide_cyclase | 1.61e-03 | 18 | 247 | 3 | IPR029787 | |
| Domain | - | 1.61e-03 | 18 | 247 | 3 | 3.30.70.1230 | |
| Domain | TPR | 1.66e-03 | 129 | 247 | 7 | SM00028 | |
| Domain | C1 | 1.68e-03 | 65 | 247 | 5 | SM00109 | |
| Domain | GST_mu | 1.70e-03 | 5 | 247 | 2 | IPR003081 | |
| Domain | Glutathione-S-Trfase_C-like | 1.71e-03 | 39 | 247 | 4 | IPR010987 | |
| Domain | - | 1.71e-03 | 39 | 247 | 4 | 1.20.1050.10 | |
| Domain | PE/DAG-bd | 1.80e-03 | 66 | 247 | 5 | IPR002219 | |
| Domain | Guanylate_cyc | 1.89e-03 | 19 | 247 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.89e-03 | 19 | 247 | 3 | PS50125 | |
| Domain | A/G_cyclase | 1.89e-03 | 19 | 247 | 3 | IPR001054 | |
| Domain | Run_dom | 1.89e-03 | 19 | 247 | 3 | IPR004012 | |
| Domain | CYCc | 1.89e-03 | 19 | 247 | 3 | SM00044 | |
| Domain | RUN | 1.89e-03 | 19 | 247 | 3 | PS50826 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.89e-03 | 19 | 247 | 3 | PS00452 | |
| Domain | RUN | 1.89e-03 | 19 | 247 | 3 | PF02759 | |
| Domain | TPR_repeat | 1.97e-03 | 133 | 247 | 7 | IPR019734 | |
| Domain | ASX_HYDROXYL | 2.13e-03 | 100 | 247 | 6 | PS00010 | |
| Domain | Adcy_conserved_dom | 2.52e-03 | 6 | 247 | 2 | IPR009398 | |
| Domain | Kinesin_assoc | 2.52e-03 | 6 | 247 | 2 | PF16183 | |
| Domain | DUF1053 | 2.52e-03 | 6 | 247 | 2 | PF06327 | |
| Domain | Kinesin_assoc | 2.52e-03 | 6 | 247 | 2 | IPR032405 | |
| Domain | ELMO | 2.52e-03 | 6 | 247 | 2 | PS51335 | |
| Domain | - | 2.52e-03 | 6 | 247 | 2 | 3.90.1290.10 | |
| Domain | ITI_HC_C | 2.52e-03 | 6 | 247 | 2 | IPR010600 | |
| Domain | ELMO_CED12 | 2.52e-03 | 6 | 247 | 2 | PF04727 | |
| Domain | Kinesin-like | 2.52e-03 | 6 | 247 | 2 | IPR022164 | |
| Domain | Haem_d1 | 2.52e-03 | 6 | 247 | 2 | IPR011048 | |
| Domain | TPR_10 | 2.52e-03 | 6 | 247 | 2 | PF13374 | |
| Domain | DUF3694 | 2.52e-03 | 6 | 247 | 2 | PF12473 | |
| Domain | ITI_HC_C | 2.52e-03 | 6 | 247 | 2 | PF06668 | |
| Domain | ELMO_dom | 2.52e-03 | 6 | 247 | 2 | IPR006816 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.86e-03 | 106 | 247 | 6 | IPR000152 | |
| Domain | GST_N | 2.92e-03 | 22 | 247 | 3 | PF02798 | |
| Domain | GST_NTER | 2.92e-03 | 22 | 247 | 3 | PS50404 | |
| Domain | Spectrin | 3.33e-03 | 23 | 247 | 3 | PF00435 | |
| Domain | Pentatricopeptide_repeat | 3.33e-03 | 23 | 247 | 3 | IPR002885 | |
| Domain | Clathrin | 3.50e-03 | 7 | 247 | 2 | PF00637 | |
| Domain | Plectin | 3.50e-03 | 7 | 247 | 2 | PF00681 | |
| Domain | CAMSAP_CH | 3.50e-03 | 7 | 247 | 2 | IPR022613 | |
| Domain | Znf_UBR | 3.50e-03 | 7 | 247 | 2 | IPR003126 | |
| Domain | CAMSAP_CH | 3.50e-03 | 7 | 247 | 2 | PF11971 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 2.37e-05 | 46 | 179 | 6 | M39828 | |
| Pathway | REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS | 6.79e-05 | 7 | 179 | 3 | MM15593 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | MYO9B FAM91A1 PLEKHG5 TAOK3 CYFIP1 DST SRGAP1 ARHGAP44 BUB1 VAV3 DOCK6 IQGAP3 KLC3 KLC1 GPS1 KLC2 ARHGAP28 TRAK2 NCF1C NCF1B SCAI | 7.70e-05 | 649 | 179 | 21 | MM15690 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | MYO9B TAOK3 CYFIP1 SRGAP1 ARHGAP44 VAV3 DOCK6 IQGAP3 NCF1C NCF1B | 7.96e-05 | 175 | 179 | 10 | MM15599 |
| Pathway | REACTOME_SIGNALING_BY_ROBO_RECEPTORS | 1.04e-04 | 20 | 179 | 4 | MM14974 | |
| Pathway | REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER | 1.12e-04 | 38 | 179 | 5 | M27592 | |
| Pathway | REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER | 1.12e-04 | 38 | 179 | 5 | MM15301 | |
| Pathway | REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY | 1.54e-04 | 22 | 179 | 4 | M27937 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.60e-04 | 9 | 179 | 3 | M47699 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 1.67e-04 | 92 | 179 | 7 | MM15823 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 2.58e-04 | 25 | 179 | 4 | M41829 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_KTN1 | 3.08e-04 | 11 | 179 | 3 | M27490 | |
| Pathway | REACTOME_PEXOPHAGY | 3.08e-04 | 11 | 179 | 3 | MM15673 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_KTN1 | 3.08e-04 | 11 | 179 | 3 | MM15218 | |
| Pathway | REACTOME_PEXOPHAGY | 3.08e-04 | 11 | 179 | 3 | M29846 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.78e-04 | 105 | 179 | 7 | MM15206 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX MELK LYST STAT3 RUSC2 FSIP2 DST SYNJ2 STARD9 SRGAP1 SYNE2 PLEC DOCK6 FOXK1 WNK3 CFAP97 KLC3 KLC1 KIF13B KLC2 RICTOR NSMCE2 SLC12A2 CEP89 CNKSR3 ASS1 TANC1 EIF3I EDRF1 CRTC2 | 1.65e-12 | 861 | 253 | 30 | 36931259 |
| Pubmed | MRPS31 IBA57 RPN1 ENTR1 DNAJC22 GTF3C3 ABRAXAS2 NCAPG SYNE2 ASPM BOP1 KLC1 HSCB GPR89B ST7 SYNE1 ZDHHC5 RICTOR VARS2 AP3B1 OGDH DARS2 WDR19 PAXBP1 SLC12A2 MRPL22 CEP89 PTCD1 MTIF2 SMU1 TTC17 TANC1 ATM FSCN1 EDRF1 | 1.04e-09 | 1487 | 253 | 35 | 33957083 | |
| Pubmed | MRPS31 SETX KIF1A GON4L FAM91A1 SCAF4 PRR12 CYFIP1 VKORC1 DST NMT2 NFRKB BOP1 IQGAP3 FOXK1 ARMC8 GPR89B PIGK SYNE1 RICTOR INO80 ATP9A AP3B1 GTF2H1 PAXBP1 GZF1 SLC12A2 PTCD1 SMU1 UNK TANC1 EIF3I EDRF1 | 1.61e-08 | 1497 | 253 | 33 | 31527615 | |
| Pubmed | SETX ZMPSTE24 ASH1L FAM91A1 PTGS2 SIAE TAOK3 UBC PTPRC RRAGD NFRKB BOP1 PLD1 PLEC HERC1 COG5 ARMC8 KIF13B CCHCR1 OGFRL1 HDAC6 RICTOR INO80 AP3B1 PAXBP1 PTCD1 LRP2 | 3.16e-08 | 1084 | 253 | 27 | 11544199 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MRPS31 SPAG1 MYO7A MELK ADCY6 SLIT2 CYFIP1 PTPRG ARHGAP44 BUB1 CDADC1 PLEC GCN1 IQGAP3 FOXK1 KLC3 KLC1 ARMC8 GPR89B KIF13B CCHCR1 GPS1 AP3B1 DARS2 WDR19 GTF2H1 SMU1 EIF2AK1 EDRF1 CRTC2 | 4.01e-08 | 1321 | 253 | 30 | 27173435 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PDS5B VPS11 SPAG1 ZMPSTE24 ELMOD2 FAM91A1 SYNJ2 SNX8 BAMBI PLD1 HERC1 TARBP1 SYNE1 ZDHHC5 KLC2 DGKD RICTOR SLC12A2 CNKSR3 TTC17 CSGALNACT1 | 8.69e-08 | 719 | 253 | 21 | 35337019 |
| Pubmed | GON4L SLIT2 UBB DST BRPF1 ASPM PLEC HERC1 SYNE1 FAT3 OGDH TERT | 1.72e-07 | 234 | 253 | 12 | 36243803 | |
| Pubmed | MRPS31 PDS5B MYH3 SPAG1 ZMPSTE24 RPN1 SPEF2 ASH1L LYST ADCY6 UBB UBC DST STARD9 SYNE2 SCN9A ASPM PLEC DNAH8 KIF13B SYNE1 ABCB5 GPS1 DUOX2 OGDH CNKSR3 ATM TNNT1 CFAP46 ZNF292 | 2.64e-07 | 1442 | 253 | 30 | 35575683 | |
| Pubmed | UBR1 SETX GON4L FAM91A1 ADCY6 RUSC2 PRR12 TAOK3 DST BUB1 DENND5A IQGAP3 RICTOR AP3B1 NPLOC4 MTIF2 TANC1 CRTC2 PLCE1 | 3.61e-07 | 650 | 253 | 19 | 38777146 | |
| Pubmed | 3.80e-07 | 3 | 253 | 3 | 36056297 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | KIF1A TUBGCP5 ITIH3 PRR12 SLIT2 NMT2 NFRKB SCN9A BOP1 INO80 FRY MTIF2 SMU1 KANK4 UNK LRRC8B | 4.92e-07 | 475 | 253 | 16 | 31040226 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO7A MYO9B PLEKHG5 LYST TBC1D24 PRR12 DST IER5L ARHGAP44 SNX8 BAMBI DENND5A PLEC HERC1 DOCK6 GCN1 SCARA3 IQGAP3 FOXK1 EPN3 ZDHHC5 SPATA20 INO80 SLC25A39 TANC1 | 6.26e-07 | 1105 | 253 | 25 | 35748872 |
| Pubmed | TUBGCP5 SCAF4 ABRAXAS2 PRR12 ZNF610 KIF13B ZDHHC5 DGKD RICTOR VARS2 FANCM PTCD1 LRRCC1 UBR3 ARHGAP28 EIF2AK1 | 8.02e-07 | 493 | 253 | 16 | 15368895 | |
| Pubmed | 1.29e-06 | 12 | 253 | 4 | 16301330 | ||
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 12354939 | ||
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 19861499 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PDS5B MYO7A MELK PLIN2 ABRAXAS2 COL24A1 CYFIP1 SYNJ2 SNX8 ASPM HERC1 HOMEZ KIF13B ANXA6 KLC2 GRIN2A ANO10 OGDH NPLOC4 DARS2 METTL24 SLC16A2 UNK TMEM30A CXCR1 CXCR2 | 1.56e-06 | 1242 | 253 | 26 | 30973865 |
| Pubmed | Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization. | 3.76e-06 | 5 | 253 | 3 | 19164528 | |
| Pubmed | Defective kinesin heavy chain behavior in mouse kinesin light chain mutants. | 3.76e-06 | 5 | 253 | 3 | 10491391 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH3 LYST MAP3K4 UBB TAOK3 UBC CYFIP1 DST NMT2 BUB1 BOP1 VAV3 PLEC FOXK1 CFAP97 KLC1 DARS2 GTF2H1 EIF3I LYN SCAI | 3.80e-06 | 910 | 253 | 21 | 36736316 |
| Pubmed | MRPS31 IBA57 TRMT2B GPR89A VARS2 ATP9A OGDH DARS2 MRPL22 MTIF2 ASS1 SLC25A19 LYN METTL15 | 4.70e-06 | 438 | 253 | 14 | 32628020 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MRPS31 TPP2 PDS5B MAP3K4 NCAPG CYFIP1 GCN1 DNAH8 IQGAP3 KLC1 KIF13B PIGK GPS1 AP3B1 DARS2 MRPL22 SMU1 FSCN1 | 4.81e-06 | 704 | 253 | 18 | 29955894 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ENTR1 FAM91A1 STAT3 SYNJ2 BRPF1 PLEC CFAP97 KLC1 TRDMT1 CCHCR1 ST7 ANXA6 KLC2 CNKSR3 LRP2 LRRCC1 UNK TTC17 TANC1 LYN | 5.16e-06 | 853 | 253 | 20 | 28718761 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B UBR1 SETX DIS3L2 RPN1 MYO9B PSMD11 MELK GTF3C3 NCAPG CYFIP1 DST ASPM BOP1 PLEC GCN1 HDAC6 DGKD RICTOR GTF2H1 MRPL22 ASS1 SMU1 TANC1 EIF3I FSCN1 | 7.23e-06 | 1353 | 253 | 26 | 29467282 |
| Pubmed | Essential role of HDAC6 in the regulation of PD-L1 in melanoma. | 7.49e-06 | 6 | 253 | 3 | 26775640 | |
| Pubmed | 7.49e-06 | 6 | 253 | 3 | 18827015 | ||
| Pubmed | 7.49e-06 | 6 | 253 | 3 | 33349630 | ||
| Pubmed | ENTR1 ASH1L TUBGCP5 ADCY6 SLIT2 ZNF610 BRPF1 NFRKB ASPM PLD1 FOXK1 HDAC6 FAT3 SAP30L RICTOR INO80 GTF2H1 MTIF2 ASS1 LRP2 LRRC8B TANC1 SLC25A19 | 8.29e-06 | 1116 | 253 | 23 | 31753913 | |
| Pubmed | DGCR6 KIF1A ASH1L TUBGCP5 STAT3 UBC DST NMT2 PLEC TARBP1 ARMC8 HDAC6 SYNE1 WDR19 FRY MTIF2 LRP2 LRRCC1 TTC17 ATM EIF2AK1 PBX1 PBX3 SCAI ZNF292 | 8.88e-06 | 1285 | 253 | 25 | 35914814 | |
| Pubmed | 1.30e-05 | 7 | 253 | 3 | 16015370 | ||
| Pubmed | 1.30e-05 | 7 | 253 | 3 | 11544318 | ||
| Pubmed | ATF4 Regulates CD4+ T Cell Immune Responses through Metabolic Reprogramming. | 1.30e-05 | 7 | 253 | 3 | 29742431 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MRPS31 IBA57 RPN1 PSMD11 TRMT2B ABRAXAS2 UBB DST SYNE2 BUB1 GPR89A BOP1 HERC1 ST7 SYNE1 VARS2 OGDH DARS2 SLC12A2 MRPL22 MTIF2 ASS1 LRP2 TTC17 TANC1 TRAK2 METTL15 | 1.47e-05 | 1496 | 253 | 27 | 32877691 |
| Pubmed | 1.75e-05 | 153 | 253 | 8 | 10718198 | ||
| Pubmed | RUSC2 and WDR47 oppositely regulate kinesin-1-dependent distribution of ATG9A to the cell periphery. | 2.07e-05 | 8 | 253 | 3 | 34432492 | |
| Pubmed | 2.17e-05 | 23 | 253 | 4 | 20468071 | ||
| Pubmed | 3.09e-05 | 9 | 253 | 3 | 22726954 | ||
| Pubmed | Two kinesin light chain genes in mice. Identification and characterization of the encoded proteins. | 3.09e-05 | 9 | 253 | 3 | 9624122 | |
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 3.60e-05 | 26 | 253 | 4 | 33905568 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EOGT KCNH8 KIF1A ASH1L PTPRG SYNJ2 ABCC8 ARHGAP44 SEMA3B DENND5A DOCK6 SCARA3 STXBP5L ST7 ANXA6 FRMPD2 NSMCE2 OGDH NPLOC4 FAM111A ASS1 TTC17 TANC1 PBX1 PBX3 METTL15 | 3.71e-05 | 1489 | 253 | 26 | 28611215 |
| Pubmed | SETX PLEKHG5 MELK TBC1D24 DST SYNJ2 BOP1 DOCK6 CFAP97 HOMEZ INO80 NPLOC4 WDR19 UNK | 3.82e-05 | 529 | 253 | 14 | 14621295 | |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 4.40e-05 | 10 | 253 | 3 | 28533284 | |
| Pubmed | ACAP1 ZMPSTE24 ELMOD2 RPN1 MYO9B PSMD11 MELK NCAPG PTPRC CSGALNACT2 BUB1 PLD1 COG5 GCN1 KLC1 PIGK ANXA6 ZDHHC5 KLC2 ANO10 AP3B1 TMEM30A | 5.06e-05 | 1168 | 253 | 22 | 19946888 | |
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 5.27e-05 | 2 | 253 | 2 | 28633507 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 28525741 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 21683347 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 10415030 | ||
| Pubmed | Regulation of the STAT3 pathway by lupus susceptibility gene Pbx1 in T cells. | 5.27e-05 | 2 | 253 | 2 | 38056350 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 9644242 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 16987681 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 11792814 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 31009605 | ||
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 5.27e-05 | 2 | 253 | 2 | 22523549 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 18851787 | ||
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 5.27e-05 | 2 | 253 | 2 | 23281318 | |
| Pubmed | Hybrid troponin reconstituted from vertebrate and arthropod subunits. | 5.27e-05 | 2 | 253 | 2 | 124018 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 32705536 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 28273454 | ||
| Pubmed | The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. | 5.27e-05 | 2 | 253 | 2 | 20044480 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 22572823 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 11173499 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 33583159 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 26156799 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 24386318 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 22171941 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 23362256 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 31162142 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 22470497 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 25173936 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 26087179 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 34730557 | ||
| Pubmed | [Leptin promotes the expression of hTERT via STAT3 in breast cancer cells]. | 5.27e-05 | 2 | 253 | 2 | 23158658 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 12393728 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 21937440 | ||
| Pubmed | Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma. | 5.27e-05 | 2 | 253 | 2 | 30054295 | |
| Pubmed | Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. | 5.27e-05 | 2 | 253 | 2 | 11822874 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 20431059 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 9605865 | ||
| Pubmed | GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus. | 5.27e-05 | 2 | 253 | 2 | 18794847 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 18177232 | ||
| Pubmed | [Expression of pSTAT3 and PD-L1 in extranodal NK/T cell lymphoma and its clinical significance]. | 5.27e-05 | 2 | 253 | 2 | 32992412 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 30343113 | ||
| Pubmed | Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. | 5.27e-05 | 2 | 253 | 2 | 12824283 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 25209998 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 21555225 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 30883650 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 21254176 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 21915051 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 35354047 | ||
| Pubmed | Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. | 5.27e-05 | 2 | 253 | 2 | 24161126 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 23609114 | ||
| Pubmed | Adenylyl cyclase type 5 protein expression during cardiac development and stress. | 5.27e-05 | 2 | 253 | 2 | 19734365 | |
| Pubmed | The second PDZ domain of scaffold protein Frmpd2 binds to GluN2A of NMDA receptors. | 5.27e-05 | 2 | 253 | 2 | 31196628 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 21036625 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 30606611 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 11397869 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 15618253 | ||
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 5.27e-05 | 2 | 253 | 2 | 24718612 | |
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 24586179 | ||
| Pubmed | 5.27e-05 | 2 | 253 | 2 | 23396948 | ||
| Interaction | DTNBP1 interactions | ENTR1 CYFIP1 DST ASPM COG5 KLC3 KLC1 CCHCR1 SYNE1 KLC2 AP3B1 DGCR6L TRAK2 | 1.27e-07 | 162 | 251 | 13 | int:DTNBP1 |
| Cytoband | 3p26-p25 | 9.04e-05 | 3 | 253 | 2 | 3p26-p25 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.15e-05 | 115 | 167 | 8 | 769 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 8.86e-05 | 10 | 167 | 3 | 53 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 5.03e-04 | 4 | 167 | 2 | 1252 | |
| GeneFamily | CD molecules|C-X-C motif chemokine receptors | 1.24e-03 | 6 | 167 | 2 | 1094 | |
| GeneFamily | Glutathione S-transferases | 1.53e-03 | 25 | 167 | 3 | 567 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.73e-03 | 7 | 167 | 2 | 785 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.29e-03 | 8 | 167 | 2 | 939 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | UBR1 HMGCR LYST PTPRC GPR89B KIF13B TMEM30A TTC17 EDRF1 ZNF292 | 1.52e-07 | 191 | 253 | 10 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.03e-07 | 197 | 253 | 10 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.13e-07 | 198 | 253 | 10 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.13e-07 | 198 | 253 | 10 | a7eed9eeb728a8796e2780090cc244856efd8c65 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.13e-07 | 198 | 253 | 10 | 88bb764b21ca50e56f6c536a2d61d35afd8c3f36 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PTGS2 PLIN2 PTPRC CSGALNACT2 SYNE2 ANPEP SYNE1 LYN CXCR1 CXCR2 | 2.13e-07 | 198 | 253 | 10 | e76061e66f6d60f5735962aa7777dda8958caed9 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RUNDC3B PTPRG SYNE2 SEMA3B SYNE1 ATP9A ITIH5 MSRB3 FRY SLC12A2 | 2.33e-07 | 200 | 253 | 10 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RUNDC3B PTPRG SYNE2 SEMA3B SYNE1 ATP9A ITIH5 MSRB3 FRY SLC12A2 | 2.33e-07 | 200 | 253 | 10 | 68fce28690246895fd33354b30960ebcc31aa4cc |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | RUNDC3B ARHGAP44 HERC1 TARBP1 STXBP5L SYNE1 GRIN2A FRY DGKI SCAI | 2.33e-07 | 200 | 253 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.33e-07 | 200 | 253 | 10 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RUNDC3B PTPRG SYNE2 SEMA3B SYNE1 ATP9A ITIH5 MSRB3 FRY SLC12A2 | 2.33e-07 | 200 | 253 | 10 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SETX SPEF2 ASH1L PLEKHG5 DST PTPRG SYNE2 DOCK6 FSCN1 CSGALNACT1 | 2.33e-07 | 200 | 253 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | SETX DST PTPRG VAV3 PLEC DOCK6 SLC12A2 TANC1 FSCN1 CSGALNACT1 | 2.33e-07 | 200 | 253 | 10 | e77eba6172cabf85b8028638ed35299f2f079cd8 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RUNDC3B PTPRG SYNE2 SEMA3B SYNE1 ATP9A ITIH5 MSRB3 FRY SLC12A2 | 2.33e-07 | 200 | 253 | 10 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RUNDC3B PTPRG SYNE2 SEMA3B SYNE1 ATP9A ITIH5 MSRB3 FRY SLC12A2 | 2.33e-07 | 200 | 253 | 10 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.33e-07 | 200 | 253 | 10 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | SETX DST PTPRG VAV3 PLEC DOCK6 SLC12A2 TANC1 FSCN1 CSGALNACT1 | 2.33e-07 | 200 | 253 | 10 | 3372c488a39fe812fa94e4f0564594186fea3db5 |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RUNDC3B PTPRG SYNE2 SEMA3B SYNE1 ATP9A ITIH5 MSRB3 FRY SLC12A2 | 2.33e-07 | 200 | 253 | 10 | 7136936d05ab344a560cf159684c881063b5430d |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-07 | 169 | 253 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-07 | 172 | 253 | 9 | 7c085c02b59e24e2a2cd393b5e692f9fb19257fe | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-07 | 172 | 253 | 9 | c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-06 | 182 | 253 | 9 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-06 | 182 | 253 | 9 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 184 | 253 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 184 | 253 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 184 | 253 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.35e-06 | 188 | 253 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-06 | 194 | 253 | 9 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-06 | 194 | 253 | 9 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.83e-06 | 195 | 253 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-06 | 196 | 253 | 9 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-06 | 197 | 253 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.99e-06 | 197 | 253 | 9 | 550cce374332c49893bcf4ce4b7dceb7f5fe26aa | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.08e-06 | 198 | 253 | 9 | 5607e36f393cb399fcc2504502498453fd32d96b | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.16e-06 | 199 | 253 | 9 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Mesenchymal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-06 | 200 | 253 | 9 | e5b7d9622b96bb20c81ac76b4e60e8b44fa9cca1 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.26e-06 | 200 | 253 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-06 | 158 | 253 | 8 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.01e-06 | 161 | 253 | 8 | 357c060e4d2ea1257c73b346dcd4a27dbc5db813 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 163 | 253 | 8 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-06 | 165 | 253 | 8 | a6c6de17fec678ad0cac3138dde3a14cc39ffd26 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.48e-06 | 168 | 253 | 8 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.98e-06 | 170 | 253 | 8 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-06 | 172 | 253 | 8 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.10e-06 | 174 | 253 | 8 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 174 | 253 | 8 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 174 | 253 | 8 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 174 | 253 | 8 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.10e-06 | 174 | 253 | 8 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-06 | 174 | 253 | 8 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.40e-06 | 175 | 253 | 8 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.72e-06 | 176 | 253 | 8 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.38e-06 | 178 | 253 | 8 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.38e-06 | 178 | 253 | 8 | bd689205bc92cda5f71df64c2332ff76adcd84b4 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.38e-06 | 178 | 253 | 8 | afcc92e8fe313c85eaf617cf4dbc3058da6c99d6 | |
| ToppCell | LPS_only-Myeloid-Neutrophils-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.73e-06 | 179 | 253 | 8 | d034651a5a355a58f5e15db627869f4feebdfe35 | |
| ToppCell | LPS_only-Myeloid-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.73e-06 | 179 | 253 | 8 | d0a03e498afcfeb657037889685ecd77bed07e6c | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.73e-06 | 179 | 253 | 8 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.13e-06 | 129 | 253 | 7 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 9.47e-06 | 181 | 253 | 8 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.60e-06 | 130 | 253 | 7 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 182 | 253 | 8 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-06 | 182 | 253 | 8 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 183 | 253 | 8 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-05 | 132 | 253 | 7 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 185 | 253 | 8 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.11e-05 | 185 | 253 | 8 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | mild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.15e-05 | 186 | 253 | 8 | 5b2e1a58916f392fa1156bf9210df528775248ff | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 186 | 253 | 8 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.20e-05 | 187 | 253 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-05 | 187 | 253 | 8 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-05 | 188 | 253 | 8 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 189 | 253 | 8 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 189 | 253 | 8 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 189 | 253 | 8 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.30e-05 | 189 | 253 | 8 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 189 | 253 | 8 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.35e-05 | 190 | 253 | 8 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 190 | 253 | 8 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.35e-05 | 190 | 253 | 8 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 190 | 253 | 8 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.40e-05 | 191 | 253 | 8 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.45e-05 | 192 | 253 | 8 | 4cd8f572e067bf5fe22f62fa868d7d332f097a8c | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.45e-05 | 192 | 253 | 8 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-05 | 192 | 253 | 8 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-05 | 192 | 253 | 8 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.51e-05 | 193 | 253 | 8 | d66cbb8c71bdc57faecb74a16fe3f34cb0b33228 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.51e-05 | 193 | 253 | 8 | c1d9c2436503791350086a503d6b98c5c69f44ae | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.51e-05 | 193 | 253 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 194 | 253 | 8 | 2224c7c943cfd5c1a329dfcf19d6e5ef8c49d85d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 194 | 253 | 8 | 50c5fc349533281a426bc7227a8ea9eca8d11985 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.57e-05 | 194 | 253 | 8 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.57e-05 | 194 | 253 | 8 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 194 | 253 | 8 | 1662b110f84584e75150df0ac970e7df82f26e7e | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-05 | 194 | 253 | 8 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.57e-05 | 194 | 253 | 8 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 194 | 253 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.57e-05 | 194 | 253 | 8 | c2ae2ea848d78725455dcb6be9f1d8933745fa80 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.57e-05 | 194 | 253 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.57e-05 | 194 | 253 | 8 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| Disease | stomach cancer (is_marker_for) | 3.42e-06 | 142 | 248 | 9 | DOID:10534 (is_marker_for) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.07e-06 | 145 | 248 | 9 | DOID:1289 (implicated_via_orthology) | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 2.00e-05 | 7 | 248 | 3 | DOID:0080348 (implicated_via_orthology) | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 2.66e-05 | 42 | 248 | 5 | DOID:8991 (is_marker_for) | |
| Disease | myeloproliferative disorder | 5.36e-05 | 25 | 248 | 4 | EFO_0004251 | |
| Disease | 3,7-dimethylurate measurement | 7.04e-05 | 2 | 248 | 2 | EFO_0800949 | |
| Disease | severe acute respiratory syndrome, COVID-19 | MYO7A RPN1 SPEF2 DRC1 LYST CNTN6 COL24A1 SYNJ2 PIK3C2G CNKSR3 UNC13C EIF2AK1 PBX1 | 1.17e-04 | 447 | 248 | 13 | EFO_0000694, MONDO_0100096 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.22e-04 | 12 | 248 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | nephroblastoma (is_marker_for) | 1.85e-04 | 34 | 248 | 4 | DOID:2154 (is_marker_for) | |
| Disease | obsolete_red blood cell distribution width | TPP2 MYO9B ENTR1 PLEKHG5 PLIN2 TAOK3 CYFIP1 IER5L SYNE2 NFRKB PLD1 HERC1 COG5 DOCK6 WNK3 TRDMT1 HSCB DUOX2 NSMCE2 AP3B1 NPLOC4 SLC12A2 PCIF1 EIF2AK1 LYN | 1.90e-04 | 1347 | 248 | 25 | EFO_0005192 |
| Disease | tyrosine-protein kinase lyn measurement | 2.10e-04 | 3 | 248 | 2 | EFO_0020827 | |
| Disease | signal transducer and activator of transcription 3 measurement | 2.10e-04 | 3 | 248 | 2 | EFO_0021907 | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 2.32e-04 | 36 | 248 | 4 | DOID:0080208 (implicated_via_orthology) | |
| Disease | Liver carcinoma | HMGCR MELK PTGS2 ITIH3 SLIT2 NCAPG PPP4R3C BUB1 ASPM IQGAP3 TERT CD274 ATM | 3.95e-04 | 507 | 248 | 13 | C2239176 |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 4.17e-04 | 4 | 248 | 2 | cv:C5574675 | |
| Disease | phenylketonuria (implicated_via_orthology) | 4.17e-04 | 4 | 248 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 4.17e-04 | 4 | 248 | 2 | C2752089 | |
| Disease | Adams-Oliver syndrome | 4.17e-04 | 4 | 248 | 2 | cv:C0265268 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 4.17e-04 | 4 | 248 | 2 | cv:CN293514 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 4.17e-04 | 4 | 248 | 2 | cv:C2752089 | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 4.17e-04 | 4 | 248 | 2 | 201300 | |
| Disease | interleukin-7 receptor subunit alpha measurement | 4.17e-04 | 4 | 248 | 2 | EFO_0020508 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 4.65e-04 | 43 | 248 | 4 | DOID:9261 (is_marker_for) | |
| Disease | Lung diseases | 5.16e-04 | 78 | 248 | 5 | C0024115 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 6.92e-04 | 5 | 248 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | proline measurement, amino acid measurement | 6.92e-04 | 5 | 248 | 2 | EFO_0005134, EFO_0009773 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 6.92e-04 | 5 | 248 | 2 | C0410190 | |
| Disease | nasal type extranodal NK/T-cell lymphoma (is_marker_for) | 6.92e-04 | 5 | 248 | 2 | DOID:0080797 (is_marker_for) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 6.92e-04 | 5 | 248 | 2 | C1450051 | |
| Disease | Brugada syndrome (implicated_via_orthology) | 6.92e-04 | 5 | 248 | 2 | DOID:0050451 (implicated_via_orthology) | |
| Disease | glutathione S-transferase Mu 1 measurement | 6.92e-04 | 5 | 248 | 2 | EFO_0801638 | |
| Disease | Fibrosis | 8.28e-04 | 50 | 248 | 4 | C0016059 | |
| Disease | Cirrhosis | 8.28e-04 | 50 | 248 | 4 | C1623038 | |
| Disease | spermatogenic failure (is_implicated_in) | 9.17e-04 | 23 | 248 | 3 | DOID:0111910 (is_implicated_in) | |
| Disease | gastric carcinoma | 9.42e-04 | 89 | 248 | 5 | EFO_0000178 | |
| Disease | Colorectal Carcinoma | ACAP1 PTGS2 NCAPG ABCC8 BUB1 SNX8 C2CD6 DNAH8 SYNE1 ABCB5 FRMPD2 GRIN2A LRP2 EDRF1 ZNF292 | 9.56e-04 | 702 | 248 | 15 | C0009402 |
| Disease | Emery-Dreifuss muscular dystrophy | 1.03e-03 | 6 | 248 | 2 | cv:C0410189 | |
| Disease | Congenital defect of skull and scalp | 1.03e-03 | 6 | 248 | 2 | C2931779 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.03e-03 | 6 | 248 | 2 | C0410189 | |
| Disease | Adams Oliver syndrome | 1.03e-03 | 6 | 248 | 2 | C0265268 | |
| Disease | Adams-Oliver syndrome 1 | 1.03e-03 | 6 | 248 | 2 | C4551482 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 1.03e-03 | 6 | 248 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | sexual dimorphism measurement | DIS3L2 KIF1A MYO9B ENTR1 HMGCR VKORC1 PNPLA1 PTPRG PLEC HERC1 GCN1 ZFAT GRIN2A AP3B1 MSRB3 ASS1 PCIF1 SCUBE3 METTL15 CSGALNACT1 | 1.15e-03 | 1106 | 248 | 20 | EFO_0021796 |
| Disease | HVA measurement | 1.32e-03 | 26 | 248 | 3 | EFO_0005131 | |
| Disease | monocyte percentage of leukocytes | NLRP12 ACAP1 RPN1 SPEF2 ADCY5 PTPRC MS4A14 COG5 CCHCR1 TERT SCUBE3 LRRC8B LYN CXCR1 CXCR2 | 1.43e-03 | 731 | 248 | 15 | EFO_0007989 |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.44e-03 | 7 | 248 | 2 | C0751337 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 1.44e-03 | 7 | 248 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | DIABETES MELLITUS, PERMANENT NEONATAL | 1.44e-03 | 7 | 248 | 2 | C1833104 | |
| Disease | apolipoprotein B measurement | HMGCR STAT3 SCAF4 NCAPG SYNE2 SNX8 PLEC DOCK6 KIF13B ZNF404 GSTM2 GSTM5 PCIF1 KANK4 | 1.57e-03 | 663 | 248 | 14 | EFO_0004615 |
| Disease | susceptibility to rheumatic fever measurement | 1.65e-03 | 28 | 248 | 3 | EFO_0008416 | |
| Disease | Malignant neoplasm of pancreas | 1.73e-03 | 102 | 248 | 5 | C0346647 | |
| Disease | HETE measurement | 1.85e-03 | 62 | 248 | 4 | EFO_0801166 | |
| Disease | microcephaly (is_implicated_in) | 1.91e-03 | 8 | 248 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | Malignant neoplasm of prostate | ASH1L PTGS2 STAT3 PTPRC BRPF1 VAV3 CCHCR1 HDAC6 TERT SLC12A2 LRP2 ATM ZNF292 | 2.29e-03 | 616 | 248 | 13 | C0376358 |
| Disease | Prostatic Neoplasms | ASH1L PTGS2 STAT3 PTPRC BRPF1 VAV3 CCHCR1 HDAC6 TERT SLC12A2 LRP2 ATM ZNF292 | 2.29e-03 | 616 | 248 | 13 | C0033578 |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 2.44e-03 | 9 | 248 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 2.44e-03 | 9 | 248 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | Middle Cerebral Artery Embolus | 2.90e-03 | 34 | 248 | 3 | C0751845 | |
| Disease | Embolic Infarction, Middle Cerebral Artery | 2.90e-03 | 34 | 248 | 3 | C0751847 | |
| Disease | Left Middle Cerebral Artery Infarction | 2.90e-03 | 34 | 248 | 3 | C0751846 | |
| Disease | Right Middle Cerebral Artery Infarction | 2.90e-03 | 34 | 248 | 3 | C0751849 | |
| Disease | Thrombotic Infarction, Middle Cerebral Artery | 2.90e-03 | 34 | 248 | 3 | C0751848 | |
| Disease | Middle Cerebral Artery Occlusion | 2.90e-03 | 34 | 248 | 3 | C0740391 | |
| Disease | Infarction, Middle Cerebral Artery | 2.90e-03 | 34 | 248 | 3 | C0740392 | |
| Disease | Middle Cerebral Artery Thrombosis | 2.90e-03 | 34 | 248 | 3 | C0740376 | |
| Disease | Middle Cerebral Artery Syndrome | 2.90e-03 | 34 | 248 | 3 | C0238281 | |
| Disease | Prescription Drug Abuse | 2.92e-03 | 115 | 248 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 2.92e-03 | 115 | 248 | 5 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.92e-03 | 115 | 248 | 5 | C0029231 | |
| Disease | Drug habituation | 2.92e-03 | 115 | 248 | 5 | C0013170 | |
| Disease | Drug abuse | 2.92e-03 | 115 | 248 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 2.92e-03 | 115 | 248 | 5 | C0013222 | |
| Disease | Drug Dependence | 2.92e-03 | 115 | 248 | 5 | C1510472 | |
| Disease | Substance Dependence | 2.92e-03 | 115 | 248 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 2.92e-03 | 115 | 248 | 5 | C0038586 | |
| Disease | Epilepsy, Myoclonic, Infantile | 3.03e-03 | 10 | 248 | 2 | C0917800 | |
| Disease | Fuchs endothelial corneal dystrophy | 3.03e-03 | 10 | 248 | 2 | Orphanet_98974 | |
| Disease | Substance abuse problem | 3.03e-03 | 116 | 248 | 5 | C0740858 | |
| Disease | Kartagener Syndrome | 3.15e-03 | 35 | 248 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 3.15e-03 | 35 | 248 | 3 | C4551906 | |
| Disease | total lipids in small HDL measurement | 3.15e-03 | 35 | 248 | 3 | EFO_0022311 | |
| Disease | Polynesian Bronchiectasis | 3.15e-03 | 35 | 248 | 3 | C4317124 | |
| Disease | hippocampal CA3 volume | 3.41e-03 | 36 | 248 | 3 | EFO_0009395 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 3.54e-03 | 74 | 248 | 4 | DOID:3748 (is_marker_for) | |
| Disease | visual epilepsy (is_implicated_in) | 3.68e-03 | 11 | 248 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | phospholipids in small HDL measurement | 3.98e-03 | 38 | 248 | 3 | EFO_0022296 | |
| Disease | Neurodegenerative Disorders | 4.29e-03 | 39 | 248 | 3 | C0524851 | |
| Disease | Degenerative Diseases, Central Nervous System | 4.29e-03 | 39 | 248 | 3 | C0270715 | |
| Disease | HVA measurement, 5-HIAA measurement | 4.29e-03 | 39 | 248 | 3 | EFO_0005131, EFO_0005132 | |
| Disease | Degenerative Diseases, Spinal Cord | 4.29e-03 | 39 | 248 | 3 | C0751733 | |
| Disease | autoimmune thyroid disease | 4.31e-03 | 126 | 248 | 5 | EFO_0006812 | |
| Disease | cesarean section, intelligence | 4.39e-03 | 12 | 248 | 2 | EFO_0004337, EFO_0009636 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 4.39e-03 | 12 | 248 | 2 | DOID:3319 (is_marker_for) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 4.39e-03 | 12 | 248 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 4.39e-03 | 12 | 248 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | phenylacetylglutamine measurement | 4.39e-03 | 12 | 248 | 2 | EFO_0021013 | |
| Disease | hemoglobin A1 measurement | MYO9B ADCY5 TAOK3 ABCC8 SYNE2 PLD1 COG5 TRDMT1 ZFAT DGKD GSAP | 4.79e-03 | 520 | 248 | 11 | EFO_0007629 |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 5.16e-03 | 13 | 248 | 2 | C0270914 | |
| Disease | Cakut | 5.16e-03 | 13 | 248 | 2 | C1968949 | |
| Disease | hypothyroidism (implicated_via_orthology) | 5.16e-03 | 13 | 248 | 2 | DOID:1459 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLKHIRTQRNYLVQT | 1091 | P23470 | |
| VASQRSVRLYHLLRQ | 596 | Q14137 | |
| ATNLYLDLRNIKRNH | 156 | Q5NDL2 | |
| QSYRLLSHINRDKLD | 2686 | Q9NR48 | |
| KIEHAAQSFYRLRLQ | 581 | Q8IYS0 | |
| SVYDLRQQSVKLHNL | 241 | Q4VNC0 | |
| LSKAIQYQQHFSRRV | 296 | Q6UX73 | |
| AQRTHRIENSLTYSK | 41 | Q8IZ81 | |
| SYREQVLHKQLTRIL | 106 | Q15018 | |
| LYHSALNRQKEQQRI | 421 | Q9P2B7 | |
| HYTNKIRALRNRLIV | 1061 | O43683 | |
| EQHRNYVSSLKRQIA | 66 | Q8TDX6 | |
| AGRIHITRATLQYLN | 511 | O43306 | |
| THQELLRNRDIYFKL | 1236 | Q2M3G0 | |
| LRRQVKNIVHNYSEA | 6 | Q9H201 | |
| RTFAQRNSLYQHIKV | 526 | Q9H116 | |
| LYVFLGIHRKRNSIQ | 76 | Q9UPC5 | |
| IRGSNTLVENLYRKH | 301 | Q9UNA3 | |
| LHLFLTVRNLKVANY | 276 | Q86SQ3 | |
| SVQGALQKHLALYRI | 131 | Q5T440 | |
| VLLDLARSYQSLKRH | 2506 | Q8IYW2 | |
| SRLSQYRKELGAQLH | 211 | Q15027 | |
| KLNYTLSQGHRVVLR | 126 | P15144 | |
| RKFRYIIHAEQNALT | 391 | Q9BWV3 | |
| AGRIHITKATLNYLN | 601 | O95622 | |
| YLAQGKNHRIIAISL | 531 | Q96PN6 | |
| QHLTEKSLYNQRLRL | 71 | Q14129 | |
| VQKRIYCNALALRSH | 791 | Q8IYB7 | |
| QSKEEHAYRLLRVLS | 61 | Q5W186 | |
| LYQFLHLRKAAITIQ | 2451 | Q8IZT6 | |
| FLSAKHQRQVYLQIR | 2896 | Q8IZT6 | |
| KLRRLYLSHNQLSEI | 151 | Q9BXN1 | |
| FININSLRLKEYHRL | 391 | P00966 | |
| YILGNRSKQHLRLVF | 201 | P08133 | |
| VRKNAAHAIQKLYSL | 166 | O00203 | |
| YEGLKRQQRTQAHLL | 46 | Q5JTZ5 | |
| SINLKRKHITYNNLS | 151 | Q7Z5Q5 | |
| VRTLHQRFLAQLRKY | 296 | P36021 | |
| VQHSSYRQRARLLKD | 76 | Q9NZQ7 | |
| INVRREYLKQHAAVS | 966 | Q9NTI5 | |
| RAYNIIRKHSQLLLN | 1101 | O75747 | |
| TRLKSQGHRVLIYSQ | 1111 | Q9ULG1 | |
| HRLGQTKQVTVYRLI | 1211 | Q9ULG1 | |
| RLKLHYNVTTTRLVN | 556 | Q14680 | |
| RLESAYQNHLILKVL | 391 | Q9NW15 | |
| FQHARKRVIATYQNI | 276 | Q9NRD9 | |
| YETLLKQRHVQLLGR | 746 | Q7L576 | |
| RAKLSQIRQIYHTEL | 151 | P40424 | |
| DYRAKLTQIRQIYHT | 151 | P40426 | |
| ESQHNYLRITRILKS | 231 | Q5TC84 | |
| ARVKGLIIQALNYHT | 246 | Q8N239 | |
| IRYLHALQITHRNLK | 171 | Q96QS6 | |
| QYFHRLLKQILASRS | 141 | Q6P4R8 | |
| VRELINTYLKQFHLA | 351 | O60551 | |
| TQSNAILRYIARKHN | 71 | P46439 | |
| LKLENLLRFHTIYRQ | 6 | P46199 | |
| ALQRAIRLLNKYVAH | 376 | Q86UX2 | |
| TRARLNALHLSDKVY | 1501 | Q86VF7 | |
| QAKRSQQLASDVHYR | 1611 | Q86VF7 | |
| RALRYIKLALQSHDT | 711 | Q3B7T1 | |
| LKTNKHIYSQLLRAT | 1191 | Q3B7T1 | |
| HRLQNVQIALDYLKR | 91 | Q03001 | |
| LQKLHTSIAGRNLYI | 631 | P04035 | |
| SIRNQLRYRNNLVKH | 41 | Q658Y4 | |
| RSIYKAISSNRQVLH | 606 | Q8IYD8 | |
| HKIYQQLSATLERAL | 1726 | Q15751 | |
| LHQSLAIARYLTKNT | 61 | O60760 | |
| LQHYANLFIRISINK | 126 | Q53TS8 | |
| LFQHARKRVIATYQN | 281 | Q9NRD8 | |
| KHLNYRTREIQSSFI | 3871 | Q5CZC0 | |
| HSKLSANVLIQRVQY | 4756 | Q5CZC0 | |
| TLYDIRAHKAQLLRF | 51 | O75564 | |
| AEAKIQQYISHRNIR | 206 | Q53H82 | |
| QIQYGIIRLLSKHRF | 296 | Q9Y5P1 | |
| KNIDRNHYRTLRQAI | 706 | O95263 | |
| LAIVHATRTLTQKRY | 146 | P25025 | |
| HVRTLYTQIRNRALI | 361 | Q13098 | |
| EYFISRSRKNLHVVL | 2936 | Q96JB1 | |
| SAITLNRQKYRHVDN | 211 | Q8TAT6 | |
| TQSNAILRYIARKHN | 71 | P28161 | |
| LDRQLNHYVKAVQST | 71 | Q96MF7 | |
| RRLNAVYLNSSSKRV | 256 | Q8N8W4 | |
| TYHNKRKIFLLVQSR | 216 | Q8NC54 | |
| YAQLHSLTLRRKATE | 561 | Q8N423 | |
| LNHIYGETLARQRKL | 216 | P35354 | |
| VRASHLLNTLYKAIL | 431 | Q96RT8 | |
| RLRTLHNLVIQYAGQ | 206 | Q6P597 | |
| KVQQYHRALVAVLLS | 561 | Q92616 | |
| TQVRIFHQLRYNKSV | 4316 | P98164 | |
| ARYVQAKLSVHDRSL | 616 | O75110 | |
| AIHQLYKQRASRLVQ | 471 | Q9Y5B6 | |
| AIYTRKDLLQRSTHI | 266 | A6NJ78 | |
| AIATHQKRDQYLRVQ | 501 | Q6R327 | |
| YATKHLRVLLRANVE | 731 | Q6R327 | |
| INRLHDILNNLRSKY | 341 | Q96MC2 | |
| HVANTLSVYRSVKRL | 61 | Q92643 | |
| LRRLHYFQKNVNSIV | 811 | Q86VI3 | |
| QLVNLKELRVYHSSL | 461 | Q6P9F7 | |
| SIHQRSRKRLSQDAY | 311 | A6NI72 | |
| SIHQRSRKRLSQDAY | 286 | A8MVU1 | |
| ARLRTLHNLVIQYAS | 196 | Q9H0B6 | |
| NSELRQKIHQTYRLQ | 256 | Q6ZMV5 | |
| RLTSRAARDYKIQNH | 331 | Q86WN1 | |
| DHLAVQSLIRAYQIR | 126 | Q02218 | |
| RNVAVVNSLYKLHQS | 576 | Q9UP83 | |
| ISRNHVTRLLQNYKK | 776 | A4D1B5 | |
| NYAFLHRTLKEILRN | 176 | Q8IUX4 | |
| LLREHKIQTNRYTVK | 2426 | Q13315 | |
| QNIAHLLTSLSYKVR | 191 | Q8IUR7 | |
| EHYQTRATSLKRQIA | 66 | Q8N6G5 | |
| SQLILKLRQHYRELC | 206 | Q9H4Z3 | |
| LVRAHYKQVATRLQS | 1016 | Q96HP0 | |
| QVNIYSVTRKRYAHL | 141 | Q16658 | |
| RYQHDGSRNLITKVQ | 126 | Q13145 | |
| QAKYIQHLTRRNSSQ | 556 | Q9BQI3 | |
| YFIVSNIRLLHKQRL | 96 | B7ZAQ6 | |
| YFIVSNIRLLHKQRL | 96 | P0CG08 | |
| VSYRKAISRAGLQHL | 131 | O75912 | |
| DRHLRTLQISYDALK | 261 | Q96C92 | |
| TVHRLNVELSRYQTK | 321 | Q96ST8 | |
| RLQAQKLRLAYTRSS | 51 | Q53ET0 | |
| SLTRHQFYLQLRKDI | 441 | Q68DX3 | |
| RTIYVTLKVNHRRNQ | 76 | Q96PZ2 | |
| LQGHERSITQIKYNR | 6 | Q13347 | |
| AYLIQKLSNARRHLE | 3716 | Q8TDW7 | |
| AQAYLTRVREALQHI | 1631 | Q3T8J9 | |
| YLAIVHATRTLTQKR | 136 | P25024 | |
| NSIRHNLSLNRYFIK | 351 | P85037 | |
| QLARAARSYHKRLVD | 291 | A2IDD5 | |
| NNRLSYAVRKVHTIR | 461 | Q8TD31 | |
| QHLTEKSLYNQRLRL | 71 | Q9BY27 | |
| LYRQNRQSKTHILET | 941 | Q9UQ52 | |
| QRNLRQFIYKNIIHS | 256 | Q96BJ8 | |
| LLHYQDNRQRKLTSG | 821 | Q6IQ26 | |
| VVLLVINHKYRNSSN | 341 | Q9NV96 | |
| RVILSLIKYNQQRVH | 1836 | Q99698 | |
| HSLNQQTKALQYLRR | 486 | Q96JA4 | |
| QTKALQYLRRHSLDV | 491 | Q96JA4 | |
| KNYIHRDLRAANVLV | 361 | P07948 | |
| GYIRIVHKNRAQTLT | 926 | Q16760 | |
| SYHRKALLAEATRQL | 126 | Q5T7N3 | |
| YSQVRKAVDNILRHL | 556 | Q5TBA9 | |
| VVYRRDQLHFKSLLS | 126 | Q8IX15 | |
| VAVAARYAQQKHRIR | 231 | Q9UBN7 | |
| FLAQRQRRIYKTTTH | 36 | O75844 | |
| ITAQRHRRYKALVAS | 161 | Q8N4W6 | |
| ARLHLTVTRAYKVNT | 156 | Q9NQL2 | |
| VHRQDAYRALQKLSR | 551 | O95104 | |
| LLVLLVHARAAQYSK | 11 | Q8IX30 | |
| SDLTTRNYARRQKHL | 366 | Q96BU1 | |
| QKNLSLHTSVRILYL | 46 | Q6AZY7 | |
| HRQRSSLAKINIVYQ | 656 | P51172 | |
| HKNLLVSYVLRNARQ | 31 | Q5T953 | |
| ARLRTLHNLVIQYAS | 211 | Q07866 | |
| TRHYLLLREKLETAQ | 1391 | Q12756 | |
| LVEAFRLKQQLHARY | 131 | O14830 | |
| RQHLSSVVFIKNRLY | 156 | O43324 | |
| AVAHAKEYIQQLRSR | 186 | Q9NWU5 | |
| RLYSKQITIAINVLH | 1441 | Q9Y6R4 | |
| LAHQIRNKQCRLYSL | 171 | Q5JXM2 | |
| DTAKLQHRYQQLQRL | 86 | Q8IWL3 | |
| LSTLRYADRAKHIVN | 341 | Q9NQT8 | |
| SIVLNKRKYRSQHII | 66 | Q96S99 | |
| VNAVALDTLLYRKHN | 366 | Q96NL0 | |
| QLAKARALHSLSQLY | 706 | Q8N2Y8 | |
| VRYRSSALLARTKNN | 41 | Q92665 | |
| QVLRALRATYQLTKA | 911 | Q5ST30 | |
| ARNHVSQAIYLLTSR | 116 | Q9GZN7 | |
| IRIHNAELQRYILAT | 541 | Q6PI48 | |
| NSYINTIKTVLRHLR | 1036 | Q9C093 | |
| YKVIQAIRNFRAIHT | 431 | Q96GJ1 | |
| VKQRYRLLGNSLNVH | 366 | O14717 | |
| INVLYNRISHAQKFR | 251 | P13805 | |
| YLLLNQVRRESKDHA | 101 | Q7Z6B7 | |
| SRELIRNIYNSFHKL | 221 | Q9Y5X2 | |
| VKHFRALQEQARTYL | 4076 | Q8NF91 | |
| IDRITLYQHLKSSLN | 6726 | Q8NF91 | |
| RIYQHLRNIQDSIAK | 1256 | Q8WXH0 | |
| LQKAISRSHRYILLT | 611 | O15056 | |
| NLSRTLILKCNSYRH | 301 | Q13393 | |
| KRLCRRYSQKLTQHT | 1766 | Q9P212 | |
| NHQLIVTRGSQKDYR | 841 | Q06033 | |
| HRLQLSKTNRTLYLF | 191 | Q00887 | |
| KRYQEALHLGSQLLR | 141 | O00231 | |
| QVLTLVNKRIGLYRH | 481 | P04843 | |
| TNQIHKKRRCSSYLL | 661 | Q15858 | |
| LLYRLLTENQRKGHS | 1976 | Q7Z333 | |
| KQTVAYRLHLGARAL | 381 | Q9HAT2 | |
| THNLKYVSSRRAVTQ | 41 | Q8IW03 | |
| RSHQLAAYRDLLIKE | 531 | Q9C0D5 | |
| TRELEYRQLHTLQKL | 656 | Q9H2K8 | |
| VVGLYQKSSNRLLAH | 606 | P11055 | |
| LLHRNITVKTYFNRT | 221 | P22891 | |
| TVKGNLLIYNHQTSR | 116 | Q8NEZ3 | |
| RLHQRVTNSISLVYL | 4576 | Q9P2P6 | |
| SQQELRKRLTPLQYH | 46 | Q8IXL7 | |
| QRYHLQSVIRTSASL | 696 | Q9ULL5 | |
| AQHRRDTNVLVYIKR | 286 | Q9NRC1 | |
| VQAEYHRKSLTLLQA | 221 | Q17R89 | |
| RHQQLLLNKGLTSYI | 96 | Q9UIY3 | |
| AILHSLKFNRERITY | 146 | Q9Y2K9 | |
| ASQKYVLRRHALIVQ | 781 | Q9Y5Q9 | |
| RISVARALYQHANVV | 836 | Q09428 | |
| KSNIRKSVQIAYHRA | 1181 | P55201 | |
| HQNQAKLVVALSRTY | 21 | Q9BPX3 | |
| LKLRASSHNLQNYIS | 86 | G9CGD6 | |
| LKLRASSHNLQNYIS | 86 | Q6P9H4 | |
| VYKRQEHQISRSQLS | 301 | Q17RW2 | |
| KVFSLLSYLARHQII | 351 | Q8N9Z0 | |
| QSHALRGKVYQRLIR | 46 | Q9ULP9 | |
| VSAQHRKLTLAQLYR | 976 | O94827 | |
| LHRLSLRRQNYLSEK | 486 | O60296 | |
| HSQYLRLRQRICKSS | 986 | Q9NR97 | |
| KIRRQYLSTNLVSHI | 511 | P32780 | |
| DKRSNYLHRQVLQVS | 361 | Q86Y38 | |
| YASAIKANLNVHLRK | 306 | Q9P243 | |
| SYVIRKFLDAQRIHN | 421 | Q9H270 | |
| KLRTCHQNRQVYRAI | 346 | P17040 | |
| VLSLYALHVKAARAR | 21 | Q9BQB6 | |
| LHNSLRIDLSKYREN | 1486 | Q8NB66 | |
| QYLKENSLHRALATL | 16 | Q2TAY7 | |
| RTKLQAQHVSYRELG | 186 | Q9BZJ4 | |
| KRHQLYVASRSAVAQ | 496 | Q13214 | |
| LFQLQVNTLRRYKRH | 111 | Q9HAJ7 | |
| HNLRRIKQFLQSRYL | 81 | P40763 | |
| LTRTQAAAVQKRYHT | 141 | Q9P2N2 | |
| AKGILQYVARSLSHR | 361 | Q8TB22 | |
| QHLSRKRIYIEDNLS | 1281 | Q9BX26 | |
| TYRQIRLNELLKEHS | 1146 | P55011 | |
| VKALLRRATTYKHQN | 276 | Q07617 | |
| SQATKYRILRSQRLA | 371 | O43280 | |
| IYATRSNLLRHIFNK | 2266 | O60281 | |
| LKANNIDYTVHSVRR | 466 | P29144 | |
| IQTVLARISGYNIRH | 1236 | Q8IWV7 | |
| RGLNSLTKLYLSHNR | 171 | Q9HBX9 | |
| YLRKINRDIAQLLTH | 506 | Q8N9R8 | |
| YKHLTLIDLSNNRIS | 776 | O94813 | |
| KLQNVQIALDYLRHR | 236 | Q15149 | |
| YLRHRQVKLVNIRND | 246 | Q15149 | |
| QHRSLQRTLNELKEY | 351 | Q96AE7 | |
| YNIQKESTLHLVLRL | 211 | P0CG47 | |
| QANQTLARYRKTVHE | 1051 | Q9H6N6 | |
| KTFRLNSQLIYHQTI | 446 | Q494X3 | |
| KRFTQNSQLYTHRRV | 491 | Q9UK10 | |
| VRYDNLSRHIVASLQ | 531 | Q9C0B5 | |
| AVHDVRLSLLQRYFK | 1291 | Q6ZT12 | |
| KAFSQSSYLIIHQRI | 376 | Q8NF99 | |
| KLHSRAYQQALSRVK | 226 | Q99541 | |
| NHNFSVRLYALVALK | 1281 | Q13395 | |
| YNIQKESTLHLVLRL | 211 | P0CG48 | |
| YNIQKESTLHLVLRL | 591 | P0CG48 | |
| NTHIYSALINAAIRK | 586 | O75127 | |
| STLYSLQKQLRAHLE | 741 | Q9C0B0 | |
| VLSLHAYIIAKVQRN | 456 | P08575 | |
| SAKYHGILQASRQIL | 56 | Q9HC21 | |
| KTFVRATQLTYHQRI | 481 | Q7Z3V5 | |
| QAFLLKLTRHRVTYV | 1076 | O14746 | |
| LINRVNSTYLVRHRT | 686 | Q9UKW4 | |
| KLRNLLYQEHSISSI | 1116 | Q9BYP7 | |
| LLQKLDRYSQHSTIV | 341 | Q96L42 | |
| KLRYIDLHSNRIDSI | 136 | Q9C099 | |
| VNLSHRYTRLLLVKE | 151 | P59046 | |
| RLQALHRSRKLHQQY | 796 | Q13402 | |
| YRHQKQSIIRLQSLC | 1021 | Q13459 | |
| KNKLRISRQHSYDNI | 1281 | Q12879 |